Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 14, 2022 - Issue
Submit an article Journal homepage
154
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States

Yitian Lang1 Department of Pharmacy, Huangpu Branch, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3926-5412View further author information
ORCID Icon,
Bin Wu2 Medical Decision and Economic Group, Department of Pharmacy, Ren Ji Hospital, South Campus, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
&
Xiaoyan Liu1 Department of Pharmacy, Huangpu Branch, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 453-463 | Received 13 Sep 2022, Accepted 29 Nov 2022, Published online: 04 Dec 2023

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (3)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.